Observational studyBJU international2022

Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.

Dennie Meijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.